[CLDX] YoY Quarter Result on 31-Mar-2010 [#Q1]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
06-May-2010
Financial Year
2010
Quarter
31-Mar-2010 [#Q1]
Profit Trend
QoQ- 49.15%
YoY- 14.56%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
Revenue 2,414 2,433 2,516 3,713 3,732 147 1,182 12.62%
PBT -17,332 -13,083 -9,574 -6,245 -7,704 -22,131 -5,626 20.60%
Tax -379 -410 -268 -6,324 -165 29,419 -885 -13.16%
NP -17,332 -13,516 -10,059 -6,582 -7,704 -22,131 -5,626 20.60%
Tax Rate - - - - - - - -
Total Cost 19,746 15,949 12,575 10,295 11,436 22,278 6,808 19.40%
Ratio Analysis
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
NP Margin -717.98 -555.53 -399.80 -177.27 -206.45 -15,014.23 -475.92 7.08%
Per Share
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
EPS -3.51 -4.04 -4.71 -3.11 -7.30 -32.78 -121.88 -44.60%
EPS Diluted -3.51 -4.04 -4.71 -3.11 -7.30 -32.78 -121.88 -44.60%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.